The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
04/03/2025
ESMO Colloquium supported by Novartis:
Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation
- Welcome and introduction
Alessandra Gennari - R&D for radioligand therapies in oncology (preclinical): Target discovery, spatial target expression and tumour microenvironment
Bart Cornelissen - Clinical drug development of radiotheranostics: Trial design, administered vs absorbed dose and the role of internal dosimetry
Alessandra Gennari - Current policy and regulatory hurdles for RLT implementation: Regulatory approval, centre accreditation and radioprotection, reimbursement
Valentina Di Iorio - Q&A and discussion
- Concluding remarks
Bart Cornelissen